Abbott Targets Teva Over Latest Simcor ANDA
Abbott and Abbott Respiratory LLC lodged the complaint over Teva's bid for U.S. Food and Drug Administration approval to market a generic Simcor, which contains niacin and simvastatin.
The plaintiff sued Teva in March and an additional three times in 2010 over Simcor. Friday's suit references Teva's bid for a green light to market tablets containing 500...
To view the full article, register now.